Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE12.9600
- TODAY'S CHANGE (%)0.6800 (5.5375%)
- Bid / Lots12.8900/ 1
- Ask / Lots13.9800/ 1
- Open / Previous Close12.2100 / 12.2800
- Day Range
- 52 Week Range
- Volume847,948
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 3129 | 12.31 |
| 09:33 ET | 1163 | 12.3 |
| 09:35 ET | 500 | 12.17 |
| 09:37 ET | 500 | 12.25 |
| 09:39 ET | 1497 | 12.35 |
| 09:42 ET | 680 | 12.255 |
| 09:44 ET | 400 | 12.22 |
| 09:46 ET | 1465 | 12.37 |
| 09:48 ET | 1112 | 12.46 |
| 09:50 ET | 500 | 12.41 |
| 09:51 ET | 200 | 12.36 |
| 09:53 ET | 400 | 12.34 |
| 09:55 ET | 1160 | 12.295 |
| 09:57 ET | 500 | 12.3 |
| 10:00 ET | 900 | 12.305 |
| 10:02 ET | 1800 | 12.42 |
| 10:04 ET | 1600 | 12.4299 |
| 10:06 ET | 2445 | 12.44 |
| 10:08 ET | 1400 | 12.415 |
| 10:09 ET | 350 | 12.42 |
| 10:11 ET | 15323 | 12.455 |
| 10:13 ET | 1200 | 12.45 |
| 10:15 ET | 1426 | 12.4 |
| 10:18 ET | 1843 | 12.435 |
| 10:20 ET | 269 | 12.42 |
| 10:22 ET | 2900 | 12.36 |
| 10:24 ET | 900 | 12.375 |
| 10:26 ET | 1000 | 12.45 |
| 10:27 ET | 700 | 12.4 |
| 10:29 ET | 300 | 12.42 |
| 10:31 ET | 640 | 12.45 |
| 10:33 ET | 1000 | 12.4 |
| 10:36 ET | 900 | 12.43 |
| 10:38 ET | 1060 | 12.39 |
| 10:40 ET | 4901 | 12.39 |
| 10:42 ET | 800 | 12.43 |
| 10:44 ET | 530 | 12.43 |
| 10:45 ET | 500 | 12.47 |
| 10:47 ET | 400 | 12.46 |
| 10:49 ET | 1435 | 12.42 |
| 10:51 ET | 7124 | 12.39 |
| 10:54 ET | 1900 | 12.445 |
| 10:56 ET | 200 | 12.43 |
| 10:58 ET | 800 | 12.41 |
| 11:00 ET | 100 | 12.42 |
| 11:02 ET | 1200 | 12.42 |
| 11:03 ET | 100 | 12.43 |
| 11:05 ET | 1109 | 12.43 |
| 11:09 ET | 500 | 12.43 |
| 11:12 ET | 1133 | 12.39 |
| 11:14 ET | 1200 | 12.38 |
| 11:16 ET | 900 | 12.42 |
| 11:18 ET | 1914 | 12.425 |
| 11:20 ET | 2363 | 12.4 |
| 11:21 ET | 676 | 12.435 |
| 11:23 ET | 612 | 12.42 |
| 11:25 ET | 1893 | 12.4 |
| 11:27 ET | 600 | 12.41 |
| 11:30 ET | 900 | 12.43 |
| 11:32 ET | 1300 | 12.445 |
| 11:34 ET | 2175 | 12.48 |
| 11:36 ET | 1500 | 12.43 |
| 11:38 ET | 500 | 12.42 |
| 11:39 ET | 456 | 12.4 |
| 11:41 ET | 1100 | 12.39 |
| 11:43 ET | 400 | 12.365 |
| 11:45 ET | 300 | 12.36 |
| 11:48 ET | 1000 | 12.345 |
| 11:50 ET | 2758 | 12.405 |
| 11:52 ET | 975 | 12.42 |
| 11:54 ET | 400 | 12.395 |
| 11:56 ET | 400 | 12.4 |
| 11:57 ET | 514 | 12.42 |
| 11:59 ET | 600 | 12.44 |
| 12:01 ET | 400 | 12.445 |
| 12:03 ET | 1050 | 12.47 |
| 12:06 ET | 400 | 12.47 |
| 12:08 ET | 800 | 12.49 |
| 12:10 ET | 2731 | 12.47 |
| 12:12 ET | 3800 | 12.45 |
| 12:14 ET | 1200 | 12.44 |
| 12:15 ET | 800 | 12.4 |
| 12:17 ET | 1656 | 12.45 |
| 12:19 ET | 400 | 12.46 |
| 12:21 ET | 400 | 12.46 |
| 12:24 ET | 1742 | 12.41 |
| 12:26 ET | 934 | 12.42 |
| 12:28 ET | 300 | 12.415 |
| 12:30 ET | 1182 | 12.4 |
| 12:32 ET | 682 | 12.395 |
| 12:33 ET | 600 | 12.39 |
| 12:35 ET | 2206 | 12.39 |
| 12:37 ET | 300 | 12.38 |
| 12:39 ET | 1445 | 12.41 |
| 12:42 ET | 2538 | 12.44 |
| 12:44 ET | 600 | 12.45 |
| 12:46 ET | 1400 | 12.485 |
| 12:48 ET | 1200 | 12.49 |
| 12:50 ET | 1050 | 12.48 |
| 12:51 ET | 1741 | 12.52 |
| 12:53 ET | 995 | 12.5 |
| 12:55 ET | 2760 | 12.54 |
| 12:57 ET | 508 | 12.59 |
| 01:00 ET | 7769 | 12.655 |
| 01:02 ET | 4947 | 12.6425 |
| 01:04 ET | 2622 | 12.6 |
| 01:06 ET | 1231 | 12.6 |
| 01:08 ET | 7325 | 12.615 |
| 01:09 ET | 700 | 12.63 |
| 01:11 ET | 2274 | 12.64 |
| 01:13 ET | 1920 | 12.6962 |
| 01:15 ET | 2559 | 12.685 |
| 01:18 ET | 2200 | 12.67 |
| 01:20 ET | 3166 | 12.67 |
| 01:22 ET | 1350 | 12.655 |
| 01:24 ET | 914 | 12.69 |
| 01:26 ET | 1000 | 12.7 |
| 01:27 ET | 816 | 12.72 |
| 01:29 ET | 2212 | 12.755 |
| 01:31 ET | 4476 | 12.67 |
| 01:33 ET | 1373 | 12.7 |
| 01:36 ET | 2700 | 12.695 |
| 01:38 ET | 2235 | 12.76 |
| 01:40 ET | 200 | 12.76 |
| 01:42 ET | 9103 | 12.74 |
| 01:44 ET | 720 | 12.72 |
| 01:45 ET | 350 | 12.72 |
| 01:47 ET | 1030 | 12.735 |
| 01:49 ET | 4697 | 12.71 |
| 01:51 ET | 2888 | 12.72 |
| 01:54 ET | 1400 | 12.735 |
| 01:56 ET | 600 | 12.74 |
| 01:58 ET | 2177 | 12.72 |
| 02:00 ET | 2100 | 12.74 |
| 02:02 ET | 3528 | 12.735 |
| 02:03 ET | 1090 | 12.74 |
| 02:05 ET | 425 | 12.735 |
| 02:07 ET | 1022 | 12.77 |
| 02:09 ET | 6209 | 12.77 |
| 02:12 ET | 3038 | 12.78 |
| 02:14 ET | 200 | 12.75 |
| 02:16 ET | 300 | 12.77 |
| 02:18 ET | 1834 | 12.78 |
| 02:20 ET | 2481 | 12.8 |
| 02:21 ET | 501 | 12.83 |
| 02:23 ET | 100 | 12.83 |
| 02:25 ET | 2014 | 12.81 |
| 02:27 ET | 800 | 12.795 |
| 02:30 ET | 950 | 12.8 |
| 02:32 ET | 690 | 12.81 |
| 02:34 ET | 550 | 12.82 |
| 02:36 ET | 2800 | 12.83 |
| 02:38 ET | 1800 | 12.88 |
| 02:39 ET | 1575 | 12.875 |
| 02:41 ET | 300 | 12.87 |
| 02:43 ET | 500 | 12.88 |
| 02:45 ET | 32948 | 12.85 |
| 02:48 ET | 3638 | 12.84 |
| 02:50 ET | 3332 | 12.87 |
| 02:52 ET | 3700 | 12.88 |
| 02:54 ET | 1628 | 12.875 |
| 02:56 ET | 600 | 12.875 |
| 02:57 ET | 1033 | 12.86 |
| 02:59 ET | 1616 | 12.88 |
| 03:01 ET | 7190 | 12.92 |
| 03:03 ET | 2247 | 12.95 |
| 03:06 ET | 300 | 12.945 |
| 03:08 ET | 1200 | 12.96 |
| 03:10 ET | 1941 | 12.91 |
| 03:12 ET | 2175 | 12.91 |
| 03:14 ET | 1350 | 12.94 |
| 03:15 ET | 4337 | 12.92 |
| 03:17 ET | 1061 | 12.92 |
| 03:19 ET | 6122 | 12.955 |
| 03:21 ET | 2757 | 12.97 |
| 03:24 ET | 4192 | 12.965 |
| 03:26 ET | 2726 | 12.99 |
| 03:28 ET | 2698 | 13 |
| 03:30 ET | 4856 | 13.02 |
| 03:32 ET | 4981 | 13.02 |
| 03:33 ET | 10579 | 12.99 |
| 03:35 ET | 3403 | 12.97 |
| 03:37 ET | 10125 | 13 |
| 03:39 ET | 1000 | 13 |
| 03:42 ET | 4826 | 13 |
| 03:44 ET | 6637 | 13.02 |
| 03:46 ET | 10538 | 13.03 |
| 03:48 ET | 4279 | 13.05 |
| 03:50 ET | 6681 | 13.0601 |
| 03:51 ET | 7202 | 13.03 |
| 03:53 ET | 10138 | 12.995 |
| 03:55 ET | 12399 | 12.99 |
| 03:57 ET | 23426 | 12.99 |
| 04:00 ET | 63507 | 12.96 |
Dec 3, 2023
Dec 1, 2023
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:39PM ET on Friday Dec 01, 2023 by Dow Jones
5:39PM ET on Friday Dec 01, 2023 by Dow JonesINVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Zentalis Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm, from 5:33AM ET on Friday Dec 01, 2023 by Dow Jones
5:33AM ET on Friday Dec 01, 2023 by Dow Jones
Nov 22, 2023
Nov 21, 2023
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 917.1M | -2.8x | --- |
Spyre Therapeutics Inc | 935.4M | -0.3x | --- |
Viridian Therapeutics Inc | 953.9M | -3.6x | --- |
Northwest Biotherapeutics Inc | 843.6M | -10.9x | --- |
Prime Medicine Inc | 827.3M | -4.6x | --- |
Verve Therapeutics Inc | 1.0B | -4.1x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company is developing a focused pipeline of oncology candidates. The Company’s product candidates include Azenosertib (ZN-c3), a Wee1 inhibitor for advanced solid tumors and hematological malignancies; ZN-d5, a B-cell lymphoma 2 (BCL-2), inhibitor for hematological malignancies and related disorders; and a heterobifunctional degrader of BCL-xL, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. The Company is evaluating azenosertib and ZN-d5 in multiple ongoing clinical trials and conducting studies to enable an Investigational New Drug (IND), application for its BCL-xL product candidate. The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 1359 Broadway, Suite 801NEW YORK, NY, United States 10018
- Phone
- 212-433-3791
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Executive Director
- Cam Gallagher
- President, Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Financial Officer, Treasurer
- Melissa Epperly
- Chief Operating Officer
- Iris Roth
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $917.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.57 |
EPS | $-4.65 |
Book Value | $7.32 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
